888ppreclinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (sine) Exportin 1 (xpo1) Antagonist Selinexor (kpt-330) in Patients (pts) with Platinum Resistant/refractory Ovarian Cancer (ovca).


Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1093/annonc/mdu338.14


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.